Breast cancer gene-expression blood test

Thursday, 01 January, 2009 | Supplied by: Applied Biosystems Pty Ltd



DiaGenic and Applied Biosystems have launched BCtect, a blood-based test for early detection of breast cancer. The test searches for a unique gene expression signature using a custom TaqMan array.

The test uses peripheral blood rather than tissue from the actual breast, providing a less invasive method of testing. It is also not affected by ethnic variation or the menopausal state of the patient, allowing for widespread use to diagnose breast cancer at an early stage.

The TaqMan Array consists of 96 TaqMan gene expression assays pre-loaded multiple times on a 384-well microfluidic card. These 384 simultaneous, real-time PCR reactions are performed without the need to use liquid-handling robots or multichannel pipettors. The array is run on the 7900HT Fast Real-time PCR System by Labindia.

 

Online: www.appliedbiosystems.com
Phone: 03 9730 8600
Related Products

InSite L. mono Glo swab test for Listeria

InSite L. mono Glo is a self-contained swab system for the simultaneous detection of...

Thermo Scientific Aquilos 2 Cryo-FIB DualBeam system

The Thermo Scientific Aquilos 2 Cryo-FIB DualBeam system is dedicated to the preparation of thin,...

Abcam engineered knockout cell lysates

Abcam's engineered knockout cell lysates enable proteomic studies by providing researchers...


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd